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Abstract
Background: Use of capsaicin or resiniferatoxin (RTX) as analgesics is an attractive therapeutic option. RTX opens the cation
channel inflammatory pain/vanilloid receptor type 1 (TRPV1) permanently and selectively removes nociceptive neurons by
Ca
2+-cytotoxicity. Paradoxically, not only nociceptors, but non-neuronal cells, including keratinocytes express full length
TRPV1 mRNA, while patient dogs and experimental animals that underwent topical treatment or anatomically targeted
molecular surgery have shown neither obvious behavioral, nor pathological side effects.
Methods: To address this paradox, we assessed the vanilloid sensitivity of the HaCaT human keratinocyte cell line and
primary keratinocytes from skin biopsies.
Results: Although both cell types express TRPV1 mRNA, neither responded to vanilloids with Ca
2+-cytotoxicity. Only ectopic
overproduction of TRPV1 rendered HaCaT cells sensitive to low doses (1–50 nM) of vanilloids. The TRPV1-mediated and non-
receptor specific Ca
2+-cytotoxity ([RTX].15 mM) could clearly be distinguished, thus keratinocytes were indeed resistant to
vanilloid-induced, TRPV1-mediated Ca
2+-entry. Having a wider therapeutic window than capsaicin, RTX was effective in
subnanomolar range, but even micromolar concentrations could not kill human keratinocytes. Keratinocytes showed orders
of magnitudes lower TRPV1 mRNA level than sensory ganglions, the bona fide therapeutic targets in human pain
management. In addition to TRPV1, TRPV1b, a dominant negative splice variant was also noted in keratinocytes.
Conclusion: TRPV1B expression, together with low TRPV1 expression, may explain the vanilloid paradox: even genuinely
TRPV1 mRNA positive cells can be spared with therapeutic (up to micromolar) doses of RTX. This additional safety
information might be useful for planning future human clinical trials.
Citation: Pecze L, Szabo ´ K, Sze ´ll M, Jo ´svay K, Kasza ´s K, et al. (2008) Human Keratinocytes Are Vanilloid Resistant. PLoS ONE 3(10): e3419. doi:10.1371/
journal.pone.0003419
Editor: Leslie B. Vosshall, The Rockefeller University, United States of America
Received July 1, 2008; Accepted September 20, 2008; Published October 14, 2008
Copyright:  2008 Pecze et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work has been supported by grants of the Hungarian Ministry of Health (552/2006), and the National Office for Research and Technology (OM-
00051/2005 and OMFB-01575/2006). ZO was also supported by MC-IRG030854-PAINKILLER; Anyos Jedlik Program NKFP-1-00019/2005; GVOP-3.3.1-05/1.-2005-05-
0057/3.0. CV was also supported by grants of the National Office for Research and Technology (OM-00051/2005 and OMFB-01575/2006) and the Hungarian
Ministry of Health (552/2006). TL was also supported by grants of the National Office for Research and Technology (OMFB-01576/2006 and OMFB-01630/2006)
and the Zoltan Magyary Postdoctoral Fellowship Fund. This paper was supported by the Ja ´nos Bolyai Research Scholarship of the Hungarian Academy of
Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: oz@acheuron.com
Introduction
Vanilloid receptor type 1 (VR1/TRPV1) is a member of the
‘‘transient receptor potential’’ (TRP) family of ion channels (20+)
that show high levels of structural homology, particularly in the 6
transmembrane and ankyrin domain regions. TRPV1 is a Ca
2+/
Na
+channel that, triggered by algesic endo-, and exovanilloids,
moderate heat, inflammatory mediators and tissue acidification,
transduces pain signals in the peripheral nervous system (PNS) [1].
TRPV1 is the cognate receptor of capsaicin (CAP), resiniferatoxin
(RTX) and various other vanilloid-like analogous phytotoxins/
irritants evolved as defense molecules in modern plants against
mammalian herbivores. Contrary to mammals, avians, descen-
dents of the dinosaurs can live a normal life without capsaicin
sensitive V1 type TRP channel [2]. Indeed, avian seed dispersers
are favored, whereas, mammalian herbivores are repelled by
plants producing fruits with CAP or other toxic vanilloids [3].
TRPV1 positive nociceptors are an intermingled subset of
primary sensory afferent neurons residing in cranial and spinal
sensory ganglia [1]. From the ganglia TRPV1-immunoreactive
fibers project to the sub-epidermis and intraepidermis in normal skin
[4]. We have previously proposed that vanilloids, especially RTX,
the most potent agonist of TRPV1, can be used to remove TRPV1
+
neurons via specific Ca
2+-cytotoxicity (i.e. necrosis) occurring within
minutes, sparing other nociceptive neurons [5,6,7,8], and the
procedure had little or any side-effect in these mammals.
ExpressionofTRPV1hasrecentlybeennotedinthebrain[9]and
various non-neuronal tissues, such as pneumocytes, urothelium, gut
epithelium, vascular endothelium, thymocytes, dendritic cells,
mastocytes, smooth muscle, fibroblast and keratinocytes [10–12].
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immunopositive to TRPV1 later turned out to be resistant to
RTX. Vanilloid-elicited chemical knock-outs and TRPV12/2
mice do not show functional abnormalities other than loss of
TRPV1-related moderate heat- and pain sensitivity [13,14], except
for somewhat impaired motility of the bladder [15]. Likewise,
creating ‘‘chemical knock-outs’’ by either systemic CAP or RTX
injection of newborn animals eliminates TRPV1 expressing neurons
in the PNS, but beyond the neurological abnormalities noted in
TRPV12/2 mice, no other gross abnormalities have been detected
[16]. All these fact point to a lack of vanilloid-responsive TRPV1 in
non-neuronal cell, while the eventual non-neuron-specific function
of the receptor or its possible splice variants remains to be clarified.
Vanilloidsensitivityofnon-neuronal cellsislikewiseakeyquestion
in the case of local vanilloid treatment. Topical application of
capsaicin cream for the treatment or prurigo [17], HIV neuropathy
[18] and other forms of neuropathies [19] was found to be an
effective therapeutic intervention. A systematic review revealed that
capsain, beside being the less expensive of the available therapeutic
options, was among the most effective ones in treating post-herpetic
neuralgia [20]. In the skin, beside the C-, and Ad fibers, epidermal
keratinocytes were also found to be TRPV1 immunopositive in a
number of studies [21–23]. Our functional approach with both
systemic and local RTX treatment, however, has determined these
cells again to be resistant. In order to further address the vanilloid
resistanceparadox andtobettercharacterizethe treatmentoftopical
application of capsaicin cream and RTX-mediated neurosurgery,
we employed different diagnostic and functional assays in HaCaT
cells [24], an immortalized human keratinocyte line. To compare
and validate results in the established HaCaT cell line, some
experiments were repeated in primary keratinocytes from skin
biopsies and primary rat DRG culture.
To complicate functionality (i.e. vanilloid inducibility) of
TRPV1 in keratinocytes, some previous reports claimed
[21,23,25] but another contradicted the inductive function of
vanilloids [26]. In addition to vanilloid resistance, we also
addressed this contradiction in this paper. Neither our short
(minutes scale) functional assays (
45Ca
2+-uptake, Co
2+-uptake, of
fluorimetric assays), nor long term (24 hr) cell survival assays
showed keratinocytes to be responsive to TRPV1 mediated CAP/
RTX effects. Nevertheless, cell survival assays show the non-
TRPV1 mediated cell death elicited by high dose of CAP/RTX.
The different concentrations of CAP/RTX between the TRPV1
mediated and non-TRPV1 mediated cell death clearly show that
the therapeutic window is larger in the case of RTX. These results
support our view that topical use of RTX containing creams may
evolve into an effective pain relief option.
Materials and Methods
Reagents
Capsaicin (CAP), N-arachidonoyl-dopamine (NADA), agonists
of TRPV1, capsazepine, a well characterized antagonist of
TRPV1, and ionomycin (IONO), a calcium ionophore, were
dissolved in DMSO (all from Sigma-Aldrich, St. Louis, MO).
Anandamide (ANA) was obtained as an emulsion (in TocrisolveH;
Tocris Bioscience, Bristol, UK). Resiniferatoxin (RTX) (LC
Laboratories, Woburn, MA) was dissolved in ethanol at 2 mg/
ml concentration and further diluted in ddH2O. Propidium iodide
(Sigma) was dissolved in PBS.
Cells and cell culture
Normal human epidermal keratinocytes (NHEK) were derived
from human skin samples obtained from esthetic surgery
operations after obtaining written informed consent from the
patients. The spontaneously immortalized human keratinocyte cell
line HaCaT was kindly provided by Dr N. E. Fusenig, Heidelberg,
Germany [27] and cultured in MIXMEM medium supplemented
with 10% FCS (Sigma-Aldrich). The differentiation of HaCaT
cells was induced by serum starvation as described [28]. Primary
DRG cultures were prepared from E16 embryonic rats with method
described previously [5] and slightly modified. Briefly, DRGs were
dissected and then processed in Hank’s balanced salt puffer until
plated in DMEM. The DMEM contained 20 mM HEPES (to
prevent acidification and stabilize pH at 7.4), 7.5% fetal bovine
serum, 7.5% horse serum, 5 mg/ml uridine supplemented with
2m g / m l 5 - f l u o r o - 2 9-deoxyuridine, and 40 ng/ml nerve growth
factor to inhibit cell division and to promote differentiation of long
neuronal processes, respectively. Cells were seeded on 25-mm glass
coverslips or on multi-well microtiter plates. Surfaces were coated
with poly-D-lysine. The cultures were selected in this medium for 2
day, at which point well differentiated neurons and nondividing cells
dominated the population. Human trigeminal ganglion neurons
were collected from human cadavers after obtaining ethical
clearance from the institutional ethical committee. The Sf9 insect
cell line, derived from pupal ovarian tissue of the fall armyworm
Spodoptera frugiperda and the HEK-293 human embryonal kidney
cell line and NIH3T3 mouse fibroblast cell line were obtained from
ATCC.
Preparation of TRPV1-YFP and TRPV1 e -expressing
HaCaT cell line
The C-terminally tagged rat TRPV1e DNA construct was
prepared in the pMTH plasmid vector as described [5]. To avoid
decrease of cell survival that occurs when TRPV1 is overex-
pressed, TRPV1e was expressed using only the basal activity of the
metallothionein (pMTH) promoter. The protein kinase C e
epitope tag allowed immunological detection. To prepare a cell
line permanently expressing TRPV1e, HaCaT cells were
transfected with the pMTH-TRPV1e plasmid using the Exgen
500 transfection reagent (Fermentas, Burlington, Canada). Trans-
fections were carried out according to the recommendations of the
manufacturer. After 24 h, cells were incubated with selection
medium, containing 0.8 mg/ml G418 (Sigma-Aldrich). The
selection medium was changed every second day. After 1 month,
G418-resistant colonies were tested with vanilloid-induced
45Ca
2+
uptake assays. A colony exhibiting capsaicin-induced
45Ca
2+
uptake 20-fold above the base line determined in comparison
with parental HaCaT cells was chosen for further studies.
45Ca
2+ uptake assay
One day before the assay, cells were seeded in 96-well flat
bottom plates (Orange Scientific, Braine-l’Alleud, Belgium) at a
density of 20.000 cells/well. Assays were performed using a
BioMek 1000 robotized liquid handler (Beckman Instruments,
Fullerton, CA). The plates were washed three times with assay
medium (Ca
2+- and Mg
2+-free Hanks’ balanced salt solution
supplemented with 0.8 mM MgCl2 and with 25 mM TRIS-HCl,
pH 7.4). The agonist effect of ANA was measured at pH 5.5
because ANA is not active at pH 7.4 [29]. The dilutions of
reagents containing
45Ca
2+ were prepared using the robot. The
45Ca
2+-uptake assay was performed for 10 min at room temper-
ature using 1.33 mCi/ml of
45Ca
2+ in 100 ml final volume/well.
To stop
45Ca
2+ uptake and remove the free isotope, cells were
washed three additional times and then lysed in 80 ml/well lysis
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-
100, 0.1% SDS, 5 mM EDTA) for 30 min. Seventy ml aliquots of
the solubilized cell extracts were mixed with 100 ml aliquots of
Keratinocytes and TRPV1
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Inc., Boston, MA) and counted in a Wallac Microbeta Trilux 1450
liquid scintillation counter (Perkin-Elmer).
Vanilloid-induced Ca
2+-cytotoxicity assay
Cells were seeded at 30 000 cells/well 24 h before adding
RTX/CAP dilutions in duplicates or quadruplicates, then the
plates were incubated for further 24 hr at 37uC. Cell survival was
determined by the colorimetric MTS assay according to the
instructions of the manufacturer (Promega, Madison, WI).
Determination of changes in [Ca
2+]i
HaCaT cells and primary keratinocytes were plated onto non-
coated sterile glass coverslips at a density of ,400.000 cells/cm
2 and
were investigated after 48 hours. Prior to the optical measurements,
cells were incubated in culture medium containing 5 mM fluo-4 AM
and 0.025% (w/v) Pluronic F-127 for 1 h, in dark, at room
temperature.Subsequently,cellswerewashedinTyrodemediumfor
10 min. Optical measurements were performed using an Olympus
IX 71 inverted microscope (Olympus, Rungis, France). The
coverslips were placed into a slotted bath chamber (37uC) at the
microscope stage and cells were superfused with Tyrode alone for at
least 10 min (control period). CAP (2 mM) was administered in the
superfusion buffer for 10 min. At the end of the assay, in situ
calibration was performed with the addition of 50 mM ionomycin.
Changesintheintracellularfreecalcium [Ca
2+]iwere determinedby
a single channel photon counting system. Cells (,30/assay) in the
75*75 mm frame were illuminated at 485 nm and the emitted light
was recorded at 535 nm. Raw data were recorded with HaemoSys
(Experimetria, Hungary) and analyzed. The results were corrected
with the decrease of fluorescence intensity in the case of untreated
cells caused bybleaching and,probably, dye effluxdue totheactivity
of efflux pumps.
Cobalt histochemistry
TRPV1e/HACaT, HaCaT and NHEK cells that had attached
to the coverslips were washed in buffer A (in mM: NaCl, 57.5;
KCl, 5; MgCl2, 2; HEPES, 10; glucose, 12; sucrose, 139; pH 7.4)
for 2 min. Cells were then incubated at 37uC in cobalt-uptake
solution (buffer A+5 mM CoCl2) containing 50 mM RTX for
10 min. Following a brief wash in buffer A, the water-soluble
cobalt taken up by the cells was precipitated by 0.12% ammonium
polysulphide (Sigma-Aldrich) put into buffer A, which resulted in
the formation of dark, water-insoluble CoS in TRPV1 positive
cells. Cells were fixed in 4% formaldehyde and mounted on glass
slides using Kaiser’s Glycerol-Gelatine (Merck, Darmstadt, FRG).
Cells were examined by a Nikon light microscope (Melville, NY).
Synchronization of HaCaT keratinocytes, and detection of
TRPV1 transcript level
Briefly, HaCaT keratinocytes were synchronized by contact
inhibition and serum starvation as it was described in details in a
previous publication [30]. The culture was released from the
quiescent state by passaging (0 h) and grown for 168 h. The
various states of HaCaT keratinocyte proliferation and differen-
tiation were monitored by propidium-iodide staining (data not
shown). Samples for mRNA expression studies were taken at time
points 0, 12, 24, 36, 48, 72, 96, 168 h, and total RNA was purified
by TRIzol reagent following the instructions of the manufacturer
(Invitrogen, Carlsbad, CA, ). cDNA was generated with oligo(dT)
and random hexamer primers from 1 mg total RNA, using the
iScriptTM cDNA synthesis kit of Bio-Rad Laboratories (Hercules,
CA, USA) in a final volume of 20 ml. Real-time RT-PCR
experiments were performed to quantify the abundance of TRPV1
and TRPV1b splice variants. Primers and probe specific for human
TRPV1 were: 59-GTGCACTCCTCGCTGTACGA-39 and 59-
CACCTCCAGCACCGAGTTCT-39 forward and reverse primers
respectively, and the TaqMan probe used was 59-FAM-TGTC-
CTGCATCGACACCTGCGAG-TAMRA-39. Primers and probe
specific for human TRPV1b were: 59-GAATGACGCCGCT-
GGCT-39 and 59-CAGCGGCRCCACCAAGAG-39 forward and
reverse primers respectively, and the TaqMan probe used was 5-
9FAM-GGGAAGATCGGGAATCGCCACGA-TAMRA-39 [31].
Real-time RT-PCR reactions were performed using iQ Supermix
and an iCycler (Bio-Rad Laboratories).
Data were compared using repeated measures (ANOVA)
followed by Dunnett’s post hoc test test to determine statistical
differences after multiple comparisons (STATISTICA). Probabil-
ity values of less than 0.05 tests were considered significant, and all
data was compared to day 0 values.
Induction of differentiation of normal human
keratinocytes by Ca
2+-treatment
Normal human epidermal keratinocytes were isolated and
cultured as described previously [32]. Briefly, human epidermal
cells were obtained from healthy individuals undergoing plastic
surgery after informed consent according to Institutional Review
Board protocol. After removal of the subcutaneous tissue and
much of the reticular dermis, the tissue samples were cut into small
strips and incubated in DispaseH solution (grade II; Roche
Diagnostics, Mannheim, Germany) overnight at 4uC. On the
following day, the epidermis was peeled off the dermis, and was
incubated in 0.25% trypsin solution (Sigma-Aldrich) at 37uC for
30 min and aspirated using a Pasteur pipette to aid cell
dissociation. The viability of the cells was always .95% as
determined by Trypan blue exclusion. A suspension of primary
epidermal cells was prepared in keratinocyte serum-free medium
(Keratinocyte SFM, Invitrogen; supplemented with antibiotic/
antimycotic solution, Sigma-Aldrich) at a density of 4610
4 cells/
cm
2 in 75 cm
2 tissue culture flasks (Corning, Corning, NY).
Human epidermal keratinocytes were cultured in Keratinocyte-
SFM in a humidified atmosphere containing 5% CO2. The
medium was changed every 2 days.
In third passage, the cells were grown up to 80–90% confluence
in 25 cm
2 tissue culture flasks (Corning). At this point (day 0) they
were fed with calcium-free keratinocyte SFM (GIBCO/BRL and
Invitrogen), supplemented or not with 1.7 mM CaCl2. Elevation a
of the calcium level in culture has been shown to induce
differentiation of human keratinocytes [33]. The culturing media
was changed on day 1, 2, 4, 6, 8, 10, when samples were also taken
for mRNA expression experiments. RNA was isolated, cDNA was
generated, and real-time RT-PCR for the detection of TRPV1
splice variants were performed as described for HaCaT keratino-
cytes. The differentiation process was monitored by following the
involucrin mRNA expression of the cells using real-time RT-PCR
(data not shown). Involucrin, a major protein of the cornified
envelop was defined as marker for keratinocyte terminal
differentiation [34].
Protein Extraction and Western Blot
Human trigeminal ganglions were excised from cadavers after
obtaining the proper ethical clearance from the institutional
ethical board of the University of Szeged. Tissue samples were
homogenized in modified RIPA buffer (50 mM Tris-HCl,
140 mM NaCl, 5 mM EDTA, 1% TritonX-100, Protease
Inhibitor Coctail - Roche) and incubated on ice for 15 minutes
to let lysis proceed. All samples were precleared by centrifugation
Keratinocytes and TRPV1
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using the BCA method (Sigma). PAGE was done as described in the
Protein Electrophoresis technical manual of Amersham Biosciences.
Protein samples were separated on 8% polyacrylamide gels, then
transferred to Millipore Immobilon PVDF membrane using Tris-
Glycine transfer buffer (0.192 M Glycine, 25 mM Tris, 20%
MetOH). Transfer was followed by blocking of the membrane (309
at RT in 5% dry milk TBS-T), incubation with primary antibody
(overnight at 4uC, in 0.5% BSA TBS-T), secondary antibody (2 h at
RT, in 1% dry milk TBS-T), results were revealed using the ECL
method (SuperSignal West Chemiluminescent Substrate - Pierce,
Hyperfilm ECL - Amersham). TBS: 50 mM Tris, 140 mM NaCl,
pH 7.6; TBS-T: TBS with 0.5% Tween-20. Antibodies used and
their dilutions: TRPV1 - 1:1000 (ABR Affinity Bioreagents #PA1-
748), ß-actin - 1:1000 (Sigma #A5060), and anti-rabbit HRP -
1:10000 (Sigma #A6154, respectively).
Flow cytofluorometry
For assessing the dependence of vanilloid cytotoxicity on the
expression level of the TRPV1 receptor, 3T3 fibroblasts stably
expressing variable levels of an YFP-tagged TRPV1 construct
were incubated with 0.1, 1 or 10 mM capsaicin for 309 then
propidium iodide was added at 3 mM end concentration and
capsaicin-induced necrosis was detected with flow cytofuorometry.
Results
When exposed to RTX/CAP, cells expressing functional
TRPV1 receptor undergo a rapid elevation of [Ca
2+]i, leading
to membrane disruption and exceptionally rapid necrosis
occurring within minutes. Taken into account the very rapid
cytotoxic effect, we have chosen a 24 h colorimetric cell survival
assays for assessing the presence of a classic TRPV1 receptor on
RTX-treated primary keratinocytes, normal and differentiated
HaCaT cells, as well as on HaCaT cells transformed with TRPV1.
Only the TRPV1-transfected HaCaT cells were sensitive to
TRPV1-dependent cytotoxicity induced by vanilloids applied at
pharmacological concentrations, corroborating our hypothesis on
the lack of functional TRPV1 receptor. Normal human epidermal
keratinocytes were sensitive only to very high concentrations of
RTX. This concentration (16 mM), however, is very close to that
(50 mM) established in a study describing a non-TRPV1 mediated
cytotoxic action of vanilloids [35] (Fig. 1A). Each keratinocyte type
was sensitive to the highest concentration of capsaicin
(300 mM)(Fig. 1B). This capsaicin concentration, 300 mM, was
equally toxic to avian cells expressing a well-described capsaicin-
insensitive TRPV1 [2], and even to insect cells (the sf9 cell line),
obviously negative for a mammalian type TRPV1 (Fig. 1C.).
Using flow cytofluorometry we assessed how the cytotoxic effect
of TRPV1 agonists depends on the TRPV1 expression level and
concentrations of agonists. Capsaicin applied at pharmacological
concentrations only killed HaCaT cells expressing the TRPV1-
YFP fusion protein above a certain threshold level, while low
TRPV1 positive cells were resistant to the applied capsaicin
concentrations, 0.1–10 mM (Fig. 2).
We detected the presence of both TRPV1 and the dominant
negative TRPV1b transcripts by real-time RT-PCR using primers
and TaqMan probes specific either to TRPV1 or TRPV1b
transcripts. The abundance of TRPV1 compared to TRPV1b was
obvious as it was detected in other tissues [31]. The Ca
2+ induced
differentiation of cultured keratinocytes was accompanied with
slight changes at the level of both transcripts (Fig 3A) with
differences among various donors, depending on the level of
differentiation in the adjacent cultures that was monitored by
involucrin expression (data not shown). While only slight changes
were detected in the transcript level of TRPV1 after HaCaT cells
exited the quiescent state and serum induced cell division occurred
(Fig 3B), the level of TRPV1b transcript increased significantly
and remained elevated throughout the experiment. The point-by-
point statistical comparison of TRPV1b transcript levels revealed
that the expression was significantly elevated at all time points
compared to day 0. The gross differences of deltaCT values of
TRPV1 and TRPV1b both in keratinocytes and HaCaT cells
suggest thirty-, and one thousand-fold differences in transcript
levels, respectively. The amount of mRNA was compared in
samples from cultured keratinocytes, human HaCaT cells and
human trigeminal ganglion. The level of the TRPV1 transcript in
keratinocytes was orders of magnitudes lower than that in
trigeminal ganglion. The level of TRPV1b transcript was
Figure 1. Keratinocytes were not killed by low dose vanilloids.
Primary human keratinocytes (NHEK), proliferating and differentiating
HaCaT keratinocytes, TRPV1-expressing HaCaT keratinocytes, HEK293
human embryonal cells, NIH3T3 mouse fibroblasts and sf9 insect cells
were grown for 24 hr on 96-well plates in the presence of indicated
concentrations of RTX (A) and CAP (B, C). Cell survival was evaluated by
the MTS bioassay. Only HaCaT cells stably transformed with TRPV1
transgene were sensitive to cytotoxicity triggered by low dose
vanilloids, while normal keratinocytes were only killed by extremely
high vanilloid doses, likewise toxic to the negative control insect cells,
HEK293 or NIH3T3 cells. Data from a representative experiment
repeated three times with similar results is shown. Values are shown
as means6SD. (*: p,0.05, t-test).
doi:10.1371/journal.pone.0003419.g001
Keratinocytes and TRPV1
PLoS ONE | www.plosone.org 4 October 2008 | Volume 3 | Issue 10 | e3419Figure 2. Transformed cells expressing low levels of TRPV1 were resistant to TRPV1-mediated capsaicin toxicity. NIH3T3 mouse
fibroblasts expressing variable levels of TRPV1-YFP fusion protein were incubated in the absence of capsaicin (A) or with different capsaicin
concentrations, 0.1 mM (B), 1 mM (C), 10 mM (D) for 309, then propidium iodide was added and the flow-cytofluorometric analysis was performed. The
M1 and M2 regions contain the intact (propidium iodide negative) TRPV1-YFP high and low positive cells, respectively. Only TRPV1 high positive cells
were sensitive to dose dependent, TRPV1 mediated killing by capsaicin (E).
doi:10.1371/journal.pone.0003419.g002
Keratinocytes and TRPV1
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HaCaT (Fig. 3C). Unlike its mRNA, TRPV1 protein was
detectable only in samples extracted from human trigeminal
ganglion (TG). (Fig. 4).
To further test vanilloid sensitivity, we determined the endo- and
exovanilloids-induced
45Ca
2+-uptake of keratinocytes and rat DRG
neuronsinarobot-based bioassay.Neitherprimarykeratinocytesnor
HaCaT cells showed
45Ca
2+ influx in response to vanilloids. On the
other hand, a HaCaT cell line established to express TRPV1
ectopically and primary DRG culture readily showed
45Ca
2+ influx
upon challenge with these agonists. The used concentrations of
agonists (CAP 2 mM, RTX 0.5 mM, N-arachidonoyl-dopamine
50 mM, Anandamide 50 mM at pH 5.5) were higher than the half-
effective concentrations for both rat and human TRPV1 receptor
determined byusorfound inliterature [29,36,37].The
45Ca
2+-influx
was completely abrogated by capsazepine (IC50<10 mMa t2mM
CAP), a bona fide channel blocker of TRPV1 (Fig 5). Differentiated
HaCaT cells were also found to lack capsaicin-induced or RTX-
induced Ca
2+-uptake (data not shown). Our genetic construct
contains a Zn
2+-inducible promoter, therefore, TRPV1 could be
expressed at different levels. Higher levels positively correlated only
with increased Vmax, and not with EC50 of the agonists (EC50
2.6 nM, RTX and 70 nM, CAP) in Ca
2+-influx assays.
Fluorimetric Ca
2+ imaging assays were carried out with
indicator dye-loaded cells that can reflect subtle changes in
[Ca
2+]i, with higher sensitivity than either isotope influx
determination in high number of cells or agonist-induced
cytotoxicity quantified by photometric methods. Both primary
human keratinocytes and HaCaT cells were tested after preload-
ing with Fluo4 in an imaging setup. While TRPV1 transfected
cells exposed to CAP showed readily detectable fluorescence
changes, neither normal HaCaT cells, nor primary keratinocytes
responded to this algesic vanilloid substance, whereas ionomycin
treatment of cells showed that the test system is functional and
Ca
2+ signal can be detected (Fig. 6).
Previous to discovery of TRPV1 capsaicin-induced Co
2+-uptake
was routinely used to identify inflammatory pain nociceptive
neurons by histochemistry [10,38–41]. In our study we found
positive staining of TRPV1e/HaCaT and rat DRG primary
culture cells treated with RTX. Non-transfected HaCaT and
NHEK cells didn’t show any TRPV1 positive staining (Fig. 7).
Discussion
Although its mechanism of action is debated, capsaicin is used
as a topical analgesic for various cutaneous disorders [42,43]. It is
thought that prolonged repetitive applications of capsaicin depletes
substance P (SP) and other neuropeptides existing in the small-
diameter afferent fibers [44], and then desensitizes TRPV1
receptor/cation channel [45]. Although transient, functional
desensitization induced by low dose vanilloids does exist [46,47],
we think that the pain relieving effect of vanilloids, i.e., extremely
high doses of capsaicin or lower doses of the more potent vanilloid
RTX are not based on desensitization based on signaling events,
Figure 3. Keratinocytes express low levels of the full length TRPV1 transcript together with transcript of the TRPV1b dominant
negative splice form. Detection of TRPV1 transcript in differentiating human cultured keratinocytes (NHEK) (A) and HaCaT cells (B) by real-time RT-
PCR. TRPV1 threshold cycle numbers normalized to the internal control 18S rRNA (delta CT) are plotted. The amount of mRNAs is inversely
proportional to the plotted threshold cycle numbers. Data are presented as means of three independent experiments. (*: p,0.05, Dunnet test). The
amount of mRNA was also compared in samples from cultured keratinocytes, human HaCaT cells and human trigeminal ganglion (C). The schematic
model of TRPV1 and TRPV1b is shown in the corresponing graphs.
doi:10.1371/journal.pone.0003419.g003
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vanilloids may specifically ablate primary afferent nociceptors [6].
In accordance with this, systemic RTX-treated animals remained
insensitive to vanilloids in their whole life. In contrast, a lower dose
of RTX injected in the paw causes only a reversible inactivation (3
weeks) of nerve endings removing only the vanilloid sensitive axons
remote to the neuronal cell body [6], allowing for of axon
regeneration. Importanly, even when TRPV1 positive neurones
were deleted, no non-neuronal side effects were detected.
Validation of vanilloid resistance of non-neuronal cell types would
provide important safety data, expanding the currently claimed
potential of the molecular neurosurgery technology.
Here we showed that RTX did not harm keratinocytes,
suggesting that capsaicin can be replaced in the dermatological
practice as soon as this agent will be registered as drug. Due to
better therapeutic window RTX can be applied topically to nerve
endings in the skin to alleviate neuropathic pain and severe
inflammations.
We validated here with different experimental means the
previous hypothesis that TRPV1 mRNA expressed both in
proliferating and in differentiated keratinocytes as well as in
HaCaT cells does not confer agonist-mediated increase in [Ca
2+]i
and subsequent cell death, analogous to that observed during
TRPV1+ sensory neuron depletion. These results draw attention
Figure 4. The TRPV1 protein level in the keratinocytes was
under detection limit in Western blotting assay. Proteins were
extracted from human trigeminal ganglion (TG), primary human
keratinocytes (NEHK) and the HaCaT cell lines. With a commercially
available polyclonal antibody only the TG expressed 94 kDa TRPV1 can
be detected (A). The equal loading of protein extracts was validated by
b-actin (,50 kDa), a common, ubiquitously expressed cytoskeletal
protein (B).
doi:10.1371/journal.pone.0003419.g004
Figure 5. Neither endo-, nor exo-vanilloids caused
45Ca
2+-influx in keratinocytes. Primary human keratinocytes (NHEK), primary culture of
DRG neurons, HaCaT keratinocytes and TRPV1 transformed HaCat keratinocytes were seeded in 96-well plates, then incubated for 10-min with
different TRPV1 agonists (capsaicin, CAP; resiniferatoxin, RTX; N-arachidonoyl-dopamine, NADA; Anandamide, ANA) and combinations of agonists and
antagonists (CAP or RTX+capsazepine, capZ) in the presence of
45Ca
2+. Cell-bound radioactivity was measured with liquid scintillation. The bars
represent mean scintillation counts per minute (c.p.m.)+SD of eight parallel samples from a representative experiment repeated three times with
similar results.
doi:10.1371/journal.pone.0003419.g005
Figure 6. Fluorometric Ca
2+ imaging showed no capsaicin-
induced Ca-signal in keratinocytes. Primary human keratinocytes
and HaCaT cells were loaded with Fluo4-AM Ca
2+-indicator then imaged
in an appropriately equipped fluorescence microscope setup. The bars
represent the increase in fluorescence upon capsaicin (2 mM) treatment
as a % of the fluorescence increase after ionomycin treatment (50 mM).
While TRPV1 transformed cells exposed to CAP showed readily
detectable fluorescence changes, neither untransformed HaCaT cells,
nor primary keratinocytes responded to this algesic vanilloid substance.
Values are shown as means6SD for 6 measurement. The significance of
differences compared with TRPV1e/HaCaT was determined with the
paired t-test, *P,0.05.
doi:10.1371/journal.pone.0003419.g006
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of conflicting observations from other laboratories working with
various diagnostic means to characterize molecular phenotype,
such as screens of TRPV1+ in various cells and tissue types.
Vanilloids in high concentrations, due to distant homology to
flavonoids, important co-factors in various red/ox systems, induce
apoptosis in number of different cell types by causing either
mitochondrial depolarization [35], or inhibition of electron
transport in the plasma membrane [48]. Thus, high doses of
vanilloids (i.e. 20–100 mM) do not require expression of TRPV1
for the cytotoxic effect. In fact, we could elicit non-TRPV1
mediated cell loss with [RTX].16 mM and [CAP].200 mM,
respectively, to demonstrate this phenomenon. Under the noted
threshold values, however, these vanilloids were harmless to cells
lacking TRPV1 expression. The dose of RTX causing non-
TRPV1-mediated cytotoxicity was ,10
4 fold higher than that
(1 nM) inducing TRPV1-dependent Ca
2+-cytotoxicity in bona fide
DRG sensory neurons [5] and ,10
8 fold higher than the dose
(0.1 pM) necessary to induce Ca
2+-cytotoxicity in a cell line
ectopically overproducing TRPV1. Our results obtained in insect
cells, an obviously TRPV1 negative control, also demonstrated the
lack of receptor specificity of high-dose vanilloids. The dose of
CAP concentrations causing non TRPV1 mediated cytotoxicity
was ,10
5 fold higher than the dose (1 nM) necessary to induce
TRPV1-dependent cytotoxicity in TRPV1 transfected cell lines.
All together, this means that RTX has a broader therapeutic
window than CAP, making it a more desirable candidate for
human clinical application.
We showed evidences that agonist-dependent, receptor-medi-
ated cytotoxic effect requires a threshold-level expression of
TRPV1. Prolonged exposure to relatively high concentration of
RTX (i.e. low micromolar) is definitely tolerated by keratinocytes
in cell culture. Levels of TRPV1 transcript in keratinocytes,
however, were orders of magnitudes lower than in human
trigeminal ganglion neurons. Conceivably, TRPV1 protein
expression below the threshold required for vanilloid sensitivity
may explain unresponsiveness to vanilloids.
However, other factors may also contribute to vanilloid
insensitivity. TRPV1 is not the only member of the TRP family
of ion channels. Functional TRPV1 is most likely a homotetramer
[49], although the existence of hetero-multimers of TRPV1 with
other members of the TRPV subfamily is possible. TRPV1 is
reportedly co-expressed with other isotypes with variable stochio-
metry in keratinocytes and other vanilloid resistant cells. For
example, TRPV2 co-expression was reported in rat DRG and
brain [50], and TRPV4 in a subset of nociceptive neurons where it
sensitizes effects of prostaglandin PGE2 in inflammatory thermal
hyperalgesia [51]. These isotypes obviously do not have dominant
negative effect in C-type sensory neurons localized in ganglia of
the peripheral nervous system or at least not at that stochiometry
and levels they are expressed. Occurrence of TRPV3 and TRPV4
has been reported in keratinocytes; TRPV4 in suprabasal
keratinocytes, whereas TRPV3 selectively in the basal layers of
the epidermis [52,53]. The presence of these receptors might have
interfered with heat sensitivity assays assessing TRPV1 function-
ality in earlier studies. Their different chemical sensitivity makes
Figure 7. Cobalt histochemistry did not show functional TRPV1 in keratinocytes. A: TRPV1e/HaCaT and rat DRG culture (insert) treated with
50 mM RTX in the presence of cobalt cations shows dark CoS precipitate. B: TRPV1e/HaCaT without RTX C–D: HaCaT and NHEK treated with 50 mM
RTX did not produce the characteristic precipitate formed in the presence of intracellular cobalt cations. Bar represents 0.2 mm.
doi:10.1371/journal.pone.0003419.g007
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tantly, due to their different ligand specificity, they might not play
a role in the response to transdermal vanilloids. On the other
hand, TRPV1 might be capable of forming hetero-oligomeric
complexes either with TRPV3 or TRPV4, as demonstrated in
ectopic expression systems [54], yet functionality of these
receptor/channels not entirely known. Co-localization of TRPV1
and TRPV1b, its splice variant in the same cell confers a dominant
negative effect and receptor inactivation in the nervous system as
well as in other tissues [31] and this rule may apply to TRPV1+
keratinocytes, in which we determined unequivocal presence of
TRPV1b. Alternatively, resistance to vanilloids can appear due to
lack of cyclin dependent kinase 5 signal transduction pathway, a
protein kinase upstream to TRPV1 that might also necessary for
channel opening [55].
Last but not least, the discrepancy between our results and
observation of others’ could be caused by false positive signals
produced by antibodies that not entirely specific to TRPV1 and
can cross-react with other TRP isotypes. Commercially, up till
now, only polyclonal antibodies were available that prepared
against peptide antigens. Linear epitopes frequently results in
antibodies of suboptimal specificity and selectivity and not even
ideal for semi-quantitative determination of the TRPV1 protein.
Dendritic cells seem to be an example of such false positive
determination of TRPV1 [56,57]. Likewise, in a number of other
papers, keratinocytes show negative TRPV1 immuno-staining,
such as immuno-positive nerve endings surrounded by apparently
unstained keratinocytes, suggesting that their anti-peptide poly-
clonal TRPV1 antibody does not recognize the protein (or its
tissue-specific splice form) in non-neuronal cells [4,58,59].
To fully characterize functionality, we have to take into
consideration that there are two pools of TRPV1 in a cell: one
in the plasma membrane (TRPV1PM) and the other in the
endoplasmic reticulum (TRPV1ER) [5].
45Ca
2+-o rC o
2+-uptake
assays can reveal the function of TRPV1PM alone, while,
flourometric Ca
2+-imaging depicts the combinations of the
TRPV1PM and TRPV1ER receptor populations. In keratinocytes
we neither have found vanilloid-induced TRPV1 mediated
response in our short term
45Ca
2+-o rC o
2+-uptake assays nor
any positive evidence of intracellular free Ca
2+ mobilization.
Previous studies with comparable means demonstrated that a
minor fraction of keratinocytes may exhibit a CAP-induced
fluorometric Ca
2+ influx signal similar to that demonstrated by one
of us in TRPV1
+ DRG neurons. However, majority of the
population showed a rather spontaneous Ca
2+ signal, again a
typical biomarker of false positive membrane activity, neutral to
either presence or absence of a vanilloid agonist [21,23].
In whole-cell voltage clamp functional bioassays carried out in
mouse keratinocytes CAP has evoked little if any Ca
2+-response,
even concentration raised up to 10 mM (i.e. CAP’s ED50=0.3mM
in TRPV1+ DRG neurons) [26] Nevertheless, the CAP-evoked
intracellular Ca
2+ increase is not a specific marker for TRPV1
function, especially if applied in high doses. TRPV1 negative cell
lines, such as activated T-lymphocytes, and Jurkat cells show readily
intracellular Ca
2+-elevation upontreatment with 200 mM CAP [48],
obviously, a mechanism distinct of vanilloid-induced receptor
mediated cation uptake. Endogenous activation of TRPV1 has
been suggested to lead to Ca
2+-dependent production of proin-
flammatory mediators such as prostaglandin E2 and interleukin-8
[21]. Our experiments in keratinocytes suggest that the increase of
pro-inflammatory mediators is attributable to a TRPV-independent,
yet not fully characterized cell necrotic pathway.
Our validated, high sensitivity and specificity bioassays proved
keratinocytes completely vanilloid resistant. Importantly, the
functional TRPV1 in keratinocytes could have made them a
problematic target seemingly able to generate unwanted side effects
and prevent future use of either transdermal capsaicin or RTX.
Based on our data here, together with the lack of effect in skin
determined in knockout or RTX-treated mice in vivo [13,14]
keratinocytes can be safely spared from vanilloid-induced, recep-
tor-mediated cytotoxicity and cell death, even when the most potent
agonist RTX will be employed in molecular neurosurgery as
proposed previous to these studies. The skin side effects of
transdermal capsaicin observed in clinical practice thus seem to be
entirely caused by the affected sensory nerves, especially to to the
CGRP and substanceP liberated inanentirely TRPV1- andsensory
nerve dependent manner, not separable from the therapeutic effect.
Two approaches might be envisageable for alleviating these side
effects – one is substitution of capsaicin with more potent vanilloids
that would rapidly kill the sensory nerves, thus paradoxically
decreasing the pain sensation and local inflammation. The second is
concomitant use of local anesthetic agents (lidocain) acting
downstream of the TRPV1 receptor. [18]
It is important to note that, in spite of the assumed presence of
TRPV1 receptor in the brain [9,60,61], capsaicin (100 nM–
100 mM) and RTX (100 nM) failed to alter the basal intracellular
Ca
2+-levels in the rat hippocampal nerve terminals [62]. Likewise,
the presence of TRPV1 transcript as shown here and reported in
cases of other cell types not necessarily means sensitivity to potent
vanilloid phytotoxins. Immunoreactivities that have recently
reported in number of diverse cell types and identified in various
central nervous system neurons can be misleading and are only
just another false positive biomarker of TRPV1. Since our
Western-blotting using protein extract from keratinocytes was
negative to TRPV1, we can not exclude the possibility that
keratinocytes do not express TRPV1 at a meaningful protein level
at all. Therefore, study of functionality in addition to diagnostics is
needed for better understanding of the in vivo status of TRPV1. All
together these results may explain the relatively modest neural/
non-neuronal side effects of the RTX-mediated molecular
neurosurgery that systemically can create ‘‘chemical knockout’’
with lack of major behavioral deviances. Our observations here
are also corroborated by the lack of obvious phenotype in
TRPV12/2 mice.
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